PIERIS PHARMACEUTICALS INC

Organization

Boston, MA, US

Ticker Symbols

NASDAQ:PIRS

SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Business Address
255 STATE STREET 9TH FLOOR BOSTON MA 02109 857-246-8998
Mailing Address
255 STATE STREET 9TH FLOOR BOSTON MA 02109
State Location
MA
State of Incorporation
NV

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Anti-cancer fusion polypeptide capable of binding both CD137 and gl...
- Patent number 11,919,931
- Issue date Mar 5, 2024
- Pieris Pharmaceuticals GmbH
- Marlon Hinner
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Lipocalin muteins with binding affinity for LAG-3
- Patent number 11,773,147
- Issue date Oct 3, 2023
- Pieris Pharmaceuticals GmbH
- Christine Rothe
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Engineered T cells and uses therefor
- Patent number 11,382,963
- Issue date Jul 12, 2022
- Pieris Pharmaceuticals GmbH
- Marlon Hinner
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods for preventing or treating certain disorders by inhibiting...
- Patent number 11,382,951
- Issue date Jul 12, 2022
- Pieris Pharmaceuticals GmbH
- Andreas Hohlbaum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Specific-binding polypeptides and uses thereof
- Patent number 11,345,728
- Issue date May 31, 2022
- Pieris Pharmaceuticals GmbH
- Marlon Hinner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Proteins specific for CD137
- Patent number 11,261,221
- Issue date Mar 1, 2022
- Pieris Pharmaceuticals GmbH
- Marlon Hinner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Lipocalin muteins with binding affinity for LAG-3
- Patent number 11,168,119
- Issue date Nov 9, 2021
- Pieris Pharmaceuticals GmbH
- Christine Rothe
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Proteins specific for calcitonin gene-related peptide
- Patent number 11,034,737
- Issue date Jun 15, 2021
- Pieris Pharmaceuticals GmbH
- Gabriele Matschiner
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Nucleic acid molecules encoding human neutrophil gelatinase-associa...
- Patent number 11,034,738
- Issue date Jun 15, 2021
- Pieris Pharmaceuticals GmbH
- Rachida SIham Bel Aiba
- G01 - MEASURING TESTING
Information Patent Grant
Fusion molecules
- Patent number 10,947,284
- Issue date Mar 16, 2021
- Pieris Pharmaceuticals GmbH
- Carsten Corvey
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Human tear lipocalin muteins which specifically bind lymphocyte act...
- Patent number 10,927,156
- Issue date Feb 23, 2021
- Pieris Pharmaceuticals GmbH
- Christine Rothe
- G01 - MEASURING TESTING
Information Patent Grant
Multi-specific polypeptide useful for localized tumor immunomodulation
- Patent number 10,927,154
- Issue date Feb 23, 2021
- Pieris Pharmaceuticals GmbH
- Shane Olwill
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-cancer fusion polypeptides, encoding nucleic acids and methods...
- Patent number 10,913,778
- Issue date Feb 9, 2021
- Pieris Pharmaceuticals GmbH
- Marlon Hinner
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-cancer fusion polypeptide
- Patent number 10,865,250
- Issue date Dec 15, 2020
- Pieris Pharmaceuticals GmbH
- Marlon Hinner
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Nucleic acid molecules encoding muteins of human lipocalin 2 with a...
- Patent number 10,787,491
- Issue date Sep 29, 2020
- Pieris Pharmaceuticals GmbH
- Marlon Hinner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Specific-binding polypeptides and uses thereof
- Patent number 10,774,119
- Issue date Sep 15, 2020
- Pieris Pharmaceuticals GmbH
- Marlon Hinner
- G01 - MEASURING TESTING
Information Patent Grant
Muteins of human lipocalin 2 (Lcn2,hNGAL) with affinity for a given...
- Patent number 10,618,941
- Issue date Apr 14, 2020
- Pieris Pharmaceuticals GmbH
- Arne Skerra
- G01 - MEASURING TESTING
Information Patent Grant
Human neutrophil gelatinase-associated lipocalin (hNGAL) muteins ca...
- Patent number 10,526,382
- Issue date Jan 7, 2020
- Pieris Pharmaceuticals GmbH
- Rachida SIham Bel Aiba
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Interleukin-17A-specific and interleukin-23-specific binding polype...
- Patent number 10,526,384
- Issue date Jan 7, 2020
- Pieris Pharmaceuticals GmbH
- Marlon Hinner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Muteins of human tear lipocalin capable of binding lymphocyte-activ...
- Patent number 10,501,510
- Issue date Dec 10, 2019
- Pieris Pharmaceuticals GmbH
- Christine Rothe
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Proteins specific for calcitonin gene-related peptide
- Patent number 10,400,016
- Issue date Sep 3, 2019
- Pieris Pharmaceuticals GmbH
- Gabriele Matschiner
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods for preventing or treating certain disorders by inhibiting...
- Patent number 10,398,754
- Issue date Sep 3, 2019
- Pieris Pharmaceuticals GmbH
- Andreas Hohlbaum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tear lipocalin muteins binding IL-4 R alpha
- Patent number 10,232,014
- Issue date Mar 19, 2019
- Pieris Pharmaceuticals GmbH
- Andreas Hohlbaum
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods and compositions for treating disorders
- Patent number 10,064,963
- Issue date Sep 4, 2018
- Pieris Pharmaceuticals GmbH
- Shane Olwill
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Muteins of tear lipocalin and methods for obtaining the same
- Patent number 10,046,027
- Issue date Aug 14, 2018
- Pieris Pharmaceuticals GmbH
- Kristian Jensen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for preventing or treating certain disorders by inhibiting...
- Patent number 10,016,483
- Issue date Jul 10, 2018
- Pieris Pharmaceuticals GmbH
- Andreas Hohlbaum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for preventing or treating disorders by increasing bioavail...
- Patent number 9,950,034
- Issue date Apr 24, 2018
- Pieris Pharmaceuticals GmbH
- Andreas Hohlbaum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Muteins with tear lipocalin having affinity to human c-met receptor...
- Patent number 9,751,920
- Issue date Sep 5, 2017
- Pieris Pharmaceuticals GmbH
- Gabriele Matschiner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tear lipocalin muteins binding IL-4 R alpha
- Patent number 9,687,524
- Issue date Jun 27, 2017
- Pieris Pharmaceuticals GmbH
- Andreas Hohlbaum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for preventing or treating disorders by increasing bioavail...
- Patent number 9,610,356
- Issue date Apr 4, 2017
- Pieris Pharmaceutical GmbH
- Andreas Hohlbaum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
NOVEL LIPOCALIN MUTEINS SPECIFIC FOR CONNECTIVE TISSUE GROWTH FACTO...
- Publication number 20240228562
- Publication date Jul 11, 2024
- Pieris Pharmaceuticals GmbH
- Marina PAVLIDOU
- G01 - MEASURING TESTING
Information Patent Application
HER2/4-1BB BISPECIFIC FUSION PROTEINS FOR THE TREATMENT OF CANCER
- Publication number 20240166764
- Publication date May 23, 2024
- Pieris Pharmaceuticals GmbH
- Markus ZETTL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HER2/4-1BB BISPECIFIC FUSION PROTEINS FOR THE TREATMENT OF CANCER
- Publication number 20240166763
- Publication date May 23, 2024
- Pieris Pharmaceuticals GmbH
- Shane OLWILL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BIOMARKER METHODS AND USES
- Publication number 20230366884
- Publication date Nov 16, 2023
- Pieris Pharmaceuticals GmbH
- Markus ZETTL
- G01 - MEASURING TESTING
Information Patent Application
MULTIMERIC IMMUNOMODULATOR TARGETING 4-1BB
- Publication number 20230227568
- Publication date Jul 20, 2023
- Pieris Pharmaceuticals GmbH
- Janet PEPER-GABRIEL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR PREVENTING OR TREATING CERTAIN DISORDERS BY INHIBITING...
- Publication number 20230021168
- Publication date Jan 19, 2023
- Pieris Pharmaceuticals GmbH
- Andreas HOHLBAUM
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ENGINEERED T CELLS AND USES THEREFOR
- Publication number 20220296690
- Publication date Sep 22, 2022
- Pieris Pharmaceuticals GmbH
- Marlon Hinner
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHALED ADMINISTRATION OF LIPOCALIN MUTEINS
- Publication number 20220168387
- Publication date Jun 2, 2022
- Pieris Pharmaceuticals GmbH
- Gabriele MATSCHINER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Novel Fusion Proteins Specific for CD137 and GPC3
- Publication number 20220153864
- Publication date May 19, 2022
- Pieris Pharmaceuticals GmbH
- Rachida Siham BEL AIBA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL PROTEINS SPECIFIC FOR CD137
- Publication number 20220144901
- Publication date May 12, 2022
- Pieris Pharmaceuticals GmbH
- Marlon HINNER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
LIPOCALIN MUTEINS WITH BINDING AFFINITY FOR LAG-3
- Publication number 20220098253
- Publication date Mar 31, 2022
- Pieris Pharmaceuticals GmbH
- Christine Rothe
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-CANCER FUSION POLYPEPTIDE
- Publication number 20210403516
- Publication date Dec 30, 2021
- Pieris Pharmaceuticals GmbH
- Marlon Hinner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL FUSION PROTEIN SPECIFIC FOR CD137 AND PD-L1
- Publication number 20210363257
- Publication date Nov 25, 2021
- Pieris Pharmaceuticals GmbH
- Marina Pavlidou
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPIES COMPRISING CD137/HER2 BISPECIFIC AGENTS AND P...
- Publication number 20210246219
- Publication date Aug 12, 2021
- Pieris Pharmaceuticals GmbH
- Ingmar Bruns
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-CANCER FUSION POLYPEPTIDE
- Publication number 20210198380
- Publication date Jul 1, 2021
- Pieris Pharmaceuticals GmbH
- Marlon Hinner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR PREVENTING OR TREATING CERTAIN DISORDERS BY INHIBITING...
- Publication number 20210145934
- Publication date May 20, 2021
- Pieris Pharmaceuticals GmbH
- Andreas HOHLBAUM
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL SPECIFIC-BINDING POLYPEPTIDES AND USES THEREOF
- Publication number 20200377563
- Publication date Dec 3, 2020
- Pieris Pharmaceuticals GmbH
- Marlon HINNER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MUTEINS OF HUMAN LIPOCALIN 2 (LCN2,HNGAL) WITH AFFINITY FOR A GIVEN...
- Publication number 20200308237
- Publication date Oct 1, 2020
- Pieris Pharmaceuticals GmbH
- Arne Skerra
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL INTERLEUKIN-17A-SPECIFIC AND INTERLEUKIN-23-SPECIFIC BINDING...
- Publication number 20200148733
- Publication date May 14, 2020
- Pieris Pharmaceuticals GmbH
- Marlon Hinner
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL PROTEINS SPECIFIC FOR ANGIOGENESIS
- Publication number 20200140501
- Publication date May 7, 2020
- Pieris Pharmaceuticals GmbH
- Rachida Siham BEL AIBA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL PROTEINS SPECIFIC FOR LAG-3
- Publication number 20200048317
- Publication date Feb 13, 2020
- Pieris Pharmaceuticals GmbH
- Christine ROTHE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS FOR PREVENTING OR TREATING CERTAIN DISORDERS BY INHIBITING...
- Publication number 20200009223
- Publication date Jan 9, 2020
- Pieris Pharmaceuticals GmbH
- Andreas HOHLBAUM
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
LIPOCALIN MUTEINS WITH BINDING AFFINITY FOR LAG-3
- Publication number 20190345207
- Publication date Nov 14, 2019
- Pieris Pharmaceuticals GmbH
- Christine Rothe
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL PROTEINS SPECIFIC FOR CALCITONIN GENE-RELATED PEPTIDE
- Publication number 20190338002
- Publication date Nov 7, 2019
- Pieris Pharmaceuticals GmbH
- Gabriele Matschiner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MUTEINS OF HUMAN LIPOCALIN 2 WITH AFFINITY FOR GLYPICAN-3 (GPC3)
- Publication number 20190309037
- Publication date Oct 10, 2019
- Pieris Pharmaceuticals GmbH
- Marlon Hinner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TEAR LIPOCALIN MUTEINS BINDING IL-4 R ALPHA
- Publication number 20190240289
- Publication date Aug 8, 2019
- AstraZeneca AB
- Andreas Hohlbaum
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS FOR PREVENTING OR TREATING CERTAIN DISORDERS BY INHIBITING...
- Publication number 20190030121
- Publication date Jan 31, 2019
- Pieris Pharmaceuticals GmbH
- Andreas HOHLBAUM
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL PROTEINS SPECIFIC FOR LAG-3
- Publication number 20190031729
- Publication date Jan 31, 2019
- Pieris Pharmaceuticals GmbH
- Christine ROTHE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MUTEINS OF TEAR LIPOCALIN AND METHODS FOR OBTAINING THE SAME
- Publication number 20190015477
- Publication date Jan 17, 2019
- Pieris Pharmaceuticals GmbH
- Kristian Jensen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-CANCER FUSION POLYPEPTIDE
- Publication number 20190010248
- Publication date Jan 10, 2019
- Pieris Pharmaceuticals GmbH
- Marlon HINNER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Trademarklast 30 trademarks

Information Trademark
79361821 - MABCALIN
- Serial number 79361821
- Registration number 7459076
- Filing date Dec 19, 2022
- Pieris Pharmaceuticals GmbH
- 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry

PIERIS PHARMACEUTICALS INC

Organization

Ticker Symbols

Business Address

Mailing Address

State Location

State of Incorporation

Patents Grantslast 30 patents

Anti-cancer fusion polypeptide capable of binding both CD137 and gl...

Lipocalin muteins with binding affinity for LAG-3

Engineered T cells and uses therefor

Methods for preventing or treating certain disorders by inhibiting...

Specific-binding polypeptides and uses thereof

Proteins specific for CD137

Lipocalin muteins with binding affinity for LAG-3

Proteins specific for calcitonin gene-related peptide

Nucleic acid molecules encoding human neutrophil gelatinase-associa...

Fusion molecules

Human tear lipocalin muteins which specifically bind lymphocyte act...

Multi-specific polypeptide useful for localized tumor immunomodulation

Anti-cancer fusion polypeptides, encoding nucleic acids and methods...

Anti-cancer fusion polypeptide

Nucleic acid molecules encoding muteins of human lipocalin 2 with a...

Specific-binding polypeptides and uses thereof

Muteins of human lipocalin 2 (Lcn2,hNGAL) with affinity for a given...

Human neutrophil gelatinase-associated lipocalin (hNGAL) muteins ca...

Interleukin-17A-specific and interleukin-23-specific binding polype...

Muteins of human tear lipocalin capable of binding lymphocyte-activ...

Proteins specific for calcitonin gene-related peptide

Methods for preventing or treating certain disorders by inhibiting...

Tear lipocalin muteins binding IL-4 R alpha

Methods and compositions for treating disorders

Muteins of tear lipocalin and methods for obtaining the same

Methods for preventing or treating certain disorders by inhibiting...

Methods for preventing or treating disorders by increasing bioavail...

Muteins with tear lipocalin having affinity to human c-met receptor...

Tear lipocalin muteins binding IL-4 R alpha

Methods for preventing or treating disorders by increasing bioavail...

Patents Applicationslast 30 patents

NOVEL LIPOCALIN MUTEINS SPECIFIC FOR CONNECTIVE TISSUE GROWTH FACTO...

HER2/4-1BB BISPECIFIC FUSION PROTEINS FOR THE TREATMENT OF CANCER

HER2/4-1BB BISPECIFIC FUSION PROTEINS FOR THE TREATMENT OF CANCER

BIOMARKER METHODS AND USES

MULTIMERIC IMMUNOMODULATOR TARGETING 4-1BB

METHODS FOR PREVENTING OR TREATING CERTAIN DISORDERS BY INHIBITING...

ENGINEERED T CELLS AND USES THEREFOR

INHALED ADMINISTRATION OF LIPOCALIN MUTEINS

Novel Fusion Proteins Specific for CD137 and GPC3

NOVEL PROTEINS SPECIFIC FOR CD137

LIPOCALIN MUTEINS WITH BINDING AFFINITY FOR LAG-3

ANTI-CANCER FUSION POLYPEPTIDE

NOVEL FUSION PROTEIN SPECIFIC FOR CD137 AND PD-L1

COMBINATION THERAPIES COMPRISING CD137/HER2 BISPECIFIC AGENTS AND P...

ANTI-CANCER FUSION POLYPEPTIDE

METHODS FOR PREVENTING OR TREATING CERTAIN DISORDERS BY INHIBITING...

NOVEL SPECIFIC-BINDING POLYPEPTIDES AND USES THEREOF

MUTEINS OF HUMAN LIPOCALIN 2 (LCN2,HNGAL) WITH AFFINITY FOR A GIVEN...

NOVEL INTERLEUKIN-17A-SPECIFIC AND INTERLEUKIN-23-SPECIFIC BINDING...

NOVEL PROTEINS SPECIFIC FOR ANGIOGENESIS

NOVEL PROTEINS SPECIFIC FOR LAG-3

METHODS FOR PREVENTING OR TREATING CERTAIN DISORDERS BY INHIBITING...

LIPOCALIN MUTEINS WITH BINDING AFFINITY FOR LAG-3

NOVEL PROTEINS SPECIFIC FOR CALCITONIN GENE-RELATED PEPTIDE

MUTEINS OF HUMAN LIPOCALIN 2 WITH AFFINITY FOR GLYPICAN-3 (GPC3)

TEAR LIPOCALIN MUTEINS BINDING IL-4 R ALPHA

METHODS FOR PREVENTING OR TREATING CERTAIN DISORDERS BY INHIBITING...

NOVEL PROTEINS SPECIFIC FOR LAG-3

MUTEINS OF TEAR LIPOCALIN AND METHODS FOR OBTAINING THE SAME

ANTI-CANCER FUSION POLYPEPTIDE

Trademarklast 30 trademarks

79361821 - MABCALIN